WallStreetZenWallStreetZen

NYSEMKT: LCTX
Lineage Cell Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for LCTX

Based on 2 analysts offering 12 month price targets for Lineage Cell Therapeutics Inc

Min Forecast
$2.00+44.93%
Avg Forecast
$5.50+298.55%
Max Forecast
$9.00+552.17%

Should I buy or sell LCTX stock?

Based on 2 analysts offering ratings for Lineage Cell Therapeutics Inc.

Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although LCTX's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates LCTX as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their LCTX stock forecasts and price targets.

LCTX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-08-27
lockedlocked$00.00+00.00%2025-06-23

1 of 1

LCTX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
LCTX$1.38$5.50+298.55%Strong Buy
TVRD$33.83$59.20+74.99%Strong Buy
FDMT$6.69$33.67+403.24%Strong Buy
ENGN$6.07$20.33+235.25%Strong Buy
ALT$3.63$17.25+375.21%Strong Buy
View Top Biotech Stocks

Lineage Cell Therapeutics Stock Forecast FAQ

Is Lineage Cell Therapeutics Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NYSEMKT: LCTX) stock is to Strong Buy LCTX stock.

Out of 2 analysts, 1 (50%) are recommending LCTX as a Strong Buy, 1 (50%) are recommending LCTX as a Buy, 0 (0%) are recommending LCTX as a Hold, 0 (0%) are recommending LCTX as a Sell, and 0 (0%) are recommending LCTX as a Strong Sell.

If you're new to stock investing, here's how to buy Lineage Cell Therapeutics stock.

What is LCTX's Price Target?

According to 2 Wall Street analysts that have issued a 1 year LCTX price target, the average LCTX price target is $5.50, with the highest LCTX stock price forecast at $9.00 and the lowest LCTX stock price forecast at $2.00.

On average, Wall Street analysts predict that Lineage Cell Therapeutics's share price could reach $5.50 by Aug 27, 2026. The average Lineage Cell Therapeutics stock price prediction forecasts a potential upside of 298.55% from the current LCTX share price of $1.38.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.